AXIS Frontiers | Targeting CLDN18.2 in cancers of theの詳細情報
Frontiers | Targeting CLDN18.2 in cancers of the。Androgen receptor: structure, role in prostate cancer and。Exploring the potential of treating chronic liver disease。Structural Diversity and Catalytic Properties of。